Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial (Q41169564)
Jump to navigation
Jump to search
scientific article published on September 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial |
scientific article published on September 2009 |
Statements
1 reference
Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial (English)
1 reference
Hagop Kantarjian
1 reference
Jorge Cortes
1 reference
Theresa Ebarb
1 reference
Bang-Ning Lee
1 reference
Nitin Jain
1 reference
James M Reuben
1 reference
Changping Li
1 reference
Hui Gao
1 reference
Evan N Cohen
1 reference
David A Scheinberg
1 reference
1 September 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference